These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2638115)

  • 1. Infusions of maprotiline in depressive out-patients.
    Libigerová E
    Act Nerv Super (Praha); 1989 Dec; 31(4):286-7. PubMed ID: 2638115
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study.
    Gastpar M; Ngo Khac T; Gilsdorf U; Baumann P
    Clin Neuropharmacol; 1986; 9 Suppl 4():434-6. PubMed ID: 3552218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of maprotiline (Ludiomil) as a 2% drinkable suspension in current psychiatric practice].
    Léger JM; Lombertie E; Malauzat D
    Ann Med Psychol (Paris); 1983 Jan; 141(1):115-22. PubMed ID: 6614718
    [No Abstract]   [Full Text] [Related]  

  • 4. [Maprotiline in psychiatric ambulatory care].
    Vinar O
    Act Nerv Super (Praha); 1982 May; 24(2):112-8. PubMed ID: 7102223
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulatory treatment of masked depressions with maprotiline].
    Vencovský E
    Act Nerv Super (Praha); 1982 May; 24(2):69-72. PubMed ID: 7102226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment of depression with 75 mg of maprotiline administered in a single dose before the evening meal].
    Vandamme G
    Lille Med; 1979 Nov; 24(9):739-40. PubMed ID: 529982
    [No Abstract]   [Full Text] [Related]  

  • 7. Maprotiline (Ludiomil)--another antidepressant.
    Med Lett Drugs Ther; 1981 Jun; 23(13):58-9. PubMed ID: 7017367
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Use of maprotiline in depressive states. Intravenous administration].
    Bukowczyk A; Wasik A; Horodnicki J; Plotczyk J
    Psychiatr Pol; 1976; 10(1):89-91. PubMed ID: 943110
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ambulatory treatment of larvate depressions with maprotiline ].
    Vencovský E
    Cesk Psychiatr; 1982 Jun; 78(3):185-9. PubMed ID: 7116496
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of therapy-resistant depressions. Results of combined infusion treatment].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1090-5. PubMed ID: 7134934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of Depression comparing divided and single doses of maprotiline (Ludiomil).
    Waxman D
    J Int Med Res; 1977; 5 Suppl 4():11-21. PubMed ID: 590606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infusion treatment of depressive conditious using Ludiomil].
    Dorninger F; Eichberger G; Steiner S
    Wien Med Wochenschr; 1976 Nov; 126(47):667-71. PubMed ID: 793202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 17. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors which affect antidepressant drug responses in a multicenter controlled trial [proceedings].
    Logue JN; Sachais BA
    Psychopharmacol Bull; 1981 Jan; 17(1):138-9. PubMed ID: 7015395
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of maprotiline in treatment of cardiac patients with left anterior hemiblock.
    Ghadirian AM; Ananth J
    Psychiatr J Univ Ott; 1989 Sep; 14(3):476-7. PubMed ID: 2678191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of maprotiline in primary and secondary anxio-depressive syndromes in the aged].
    Volpi F
    Clin Ter; 1983 Jul; 106(2):95-101. PubMed ID: 6627888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.